NAT10 and hepatocellular carcinoma: Collectively, these findings suggest that integrating readily available biomarkers such as HALP, FIB-4, and GPR with conventional morphologic features could enhance the stratification of HCC patients prior to liver transplantation and help identify individuals at higher risk for recurrence and mortality.